We are pleased to welcome Shantanu Narayen to Pfizer's Board of Directors. He brings both leadership experience and a strong technology background to Pfizer's Board and will be an excellent asset to the company.
We are pleased to have Jim Smith join Pfizer's Board of Directors. He brings leadership and operational and international business experience to Pfizer's Board, and will be an excellent asset to the company.
Amy is a recognized leader in the development and growth of global pharmaceutical businesses, and she will bring this expertise to our Board as we continue to build Alnylam as a leading biotechnology company. As the former General Counsel at Pfizer, Amy also brings deep legal expertise to our Board.